What does PATH EX do?
PATH EX is a medical device company based in Houston, TX that is developing CycloPE®, a device designed to rapidly eradicate bacteria from the bloodstream in patients suffering from sepsis.
How much did they raise?
The company raised $5M in financing, with the round led by IAG Capital Partners and participation from TMC Venture Fund and Fitz Gate Ventures.
What are their plans for the money?
The funds will be used to accelerate the development and future commercialization of CycloPE®, with the aim of improving treatment outcomes for sepsis patients.
What have they achieved so far?
Alongside the financing, PATH EX strengthened its leadership by adding Jeff Burbank to its Board of Directors.
